Directorate Change

Victrex plc is an innovative world leader in high performance polymer solutions, delivering sustainable products which enable environmental and societal benefit in multiple end-markets. The Group is pleased to announce that Urmi Prasad Richardson has been appointed as a non-executive director of the Board, effective from 1st May 2024.

Commenting on the appointment:

Dr Vivienne Cox DBE, Chair of Victrex, said: "I am delighted to welcome Urmi to the Victrex Board. She brings a wealth of relevant experience across a number of global companies, with an emphasis on medical, science-based innovation, clinical scalability and healthcare. Medical is a key part of the Victrex Group and one where we have made good progress in starting to unlock its true potential. Our products support improved clinical outcomes and our goal is to double revenues in our Medical business over the next five years.

"Victrex has faced challenging trading conditions over the past year, in line with the wider Chemical sector. However, with a wealth of growth opportunities, high levels of innovation and well invested assets, the Board remains focused on the delivery of our strategy."

Career history:

Urmi has a wealth of global experience in executive and non-executive roles over a 25 year period. She has a particular focus on science, medical and innovation based businesses. Urmi is currently President EMEA of Thermo Fisher Scientific, a world leader in serving science, with products which help accelerate life science research and improve patient health. Her executive career includes roles at The Linde Group, where she was Global Head of Healthcare, at Novartis and Foundation Medicine (a Roche company). She started her career with G.D. Searle (a Pfizer company) and has worked throughout Europe and the US. Urmi has extensive experience in strategy, business development and product commercialisation in Europe, Asia and North America.

Urmi holds a number of advisory Board roles at unlisted organisations in the sectors of longevity, blockchain, and targeted therapy in oncology. Her previous non-executive roles include Linde Healthcare.

There is no further information to be disclosed under Listing Rule 9.6.13.

Victrex plc:

Andrew Hanson, Director of Investor Relations, Corporate Communications & ESG